TMX Group, Khiron, C-Suite at The Open

Canada NewsWire

TORONTO, Nov. 25, 2020 /CNW/ – Alvaro Torres, CEO, Khiron Life Sciences Corp. (TSXV: KHRN), shares his company’s story in an interview with TMX Group.

The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html.


About Khiron Life Sciences Corp. (TSXV: KHRN)

Khiron Life Sciences Corp. is the dominant integrated medical cannabis company in Latin America. It has core operations in Latin America, along with activity in North America and Europe, and is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The company addresses priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market. Its segments include Medical cannabis products, Health services, and Wellbeing products. Its operations in Latin America derives majority of the revenue. For more information visit: http://www.khiron.ca/ 


About TMX Group (TSX: X)

TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup.

SOURCE TMX Group Limited

CACC INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Credit Acceptance Corporation

PR Newswire

NEW YORK, Nov. 25, 2020 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Credit Acceptance Corp. (“Credit Acceptance” or the “Company”) (NASDAQ: CACC) from November 1, 2019 through August 28, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Eastern District of Michigan alleges violations of the Securities Exchange Act of 1934.

If you purchased Credit Acceptance Corporation securities, and/or would like to discuss your legal rights and options please visit Credit Acceptance Corp. Shareholder Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) that the Company was topping off the pools of loans that they packaged and securitized with higher-risk loans; (ii) that Credit Acceptance was making high-interest subprime auto loans to borrowers that the Company knew borrowers would be unable to repay; (iii) that the borrowers were subject to hidden finance charges, resulting in loans exceeding the usury rate ceiling mandated by state law; (iv) that Credit Acceptance took excessive and illegal measures to collect debt from defaulted borrowers; (v) that, as a result, the Company was likely to face regulatory scrutiny and possible penalties from various regulators or lawsuits; and (vi) that, as a result of the foregoing, Defendant’s positive statements about the Company’s business, operations, and adherence to appropriate laws and regulations were materially misleading and/or lacked a reasonable basis.

On August 28, 2020, the Massachusetts Attorney General (“Mass AG”) filed a lawsuit against Credit Acceptance alleging that the Company has, for years, been making unfair and deceptive automobile loans to thousands of Massachusetts consumers.  Additionally, the lawsuit alleges that Credit Acceptance provided its investors with false and/or misleading information regarding the asset-backed securitizations they offered to investors, and that the Company engaged in unfair debt collection practices as well.   In response to the public disclosure of the Mass AG lawsuit, Credit Acceptance’s stock price fell $85.36 per share, or over 18%, to close at $374.07 per share over two trading days ending on September 1, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than December 1, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Credit Acceptance securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/creditacceptancecorp-cacc-shareholder-class-action-lawsuit-stock-fraud-298/apply/ contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:


Matthew E. Guarnero


Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cacc-investor-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-credit-acceptance-corporation-301177878.html

SOURCE Bernstein Liebhard LLP

IIROC Trading Halt – NDM

Canada NewsWire

TORONTO, Nov. 25, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: Northern Dynasty Minerals Ltd.

TSX Symbol: NDM

All Issues: No

Reason: Single-Stock Circuit Breaker

Halt Time (ET): 12:57 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Barbecue At Home By Dickey’s ‘Cues the Savings with Epic Black Friday and Cyber Monday Sale

Barbecue retailer hosts site wide sale with never-before seen deals including lifetime supplies of sausage, 50% off subscriptions and more

Dallas, TX, Nov. 25, 2020 (GLOBE NEWSWIRE) — Barbecue meal subscription service and online retailer Barbecue At Home is hosting an unprecedented Black Friday and Cyber Monday sitewide event featuring deals on their most popular items.  

Beginning this week on athome.dickeys.com barbecue fans, online shoppers and holiday gifters can score a variety of limited-time deals including:

  • 50% off the first month for all meal delivery subscription boxes and receive a lifetime subscription supply of Dickey’s authentic, Texas-style kielbasa sausage ropes with purchase.
  • Orders over $99.99 receive a complimentary four rope sampler of Dickey’s famous small-batch craft sausages.
  • Free shipping and 50% off Dickey’s Ultimate Sausage Variety Box, which includes 20 variations of sausage ranging from classic flavors like cheddar jalapeño to new mixes such as loaded nacho, chipotle pepper jack and maple pancake breakfast sausage.

In addition, on Friday from 10 a.m. to 8 p.m. CST Black Friday shoppers can score 50% off the entire site using the code BLACKFRIDAY50 at checkout to save on barbecue favorites such as Dickey’s original barbecue sauce, rubs, cookbooks and other grilling merchandise.

Cyber Monday shoppers can also score big ahead of gifting season when they use code CYBERMONDAY50 at checkout to receive 50% off their order from athome.dickeys.com.

“This is hands down our biggest sale to date. Whether you’re shopping for yourself or others, Barbecue At Home has something for everyone to enjoy and this year, the deals are just too good to pass up,” said Laura Rea Dickey, CEO of Dickey’s Barbecue Restaurants, Inc.

To learn more, follow Barbecue At Home on Facebook and Instagram. Join the Barbecue At Home E-Club here to receive information on new products, recipes, and promotions.

About Dickey’s Barbecue Restaurants, Inc.

Dickey’s Barbecue Restaurants, Inc., the world’s largest barbecue concept, was founded in 1941 by Travis Dickey. For the past 79 years, Dickey’s Barbecue Pit has served millions of guests Legit. Texas. Barbecue.™ At Dickey’s, all our barbecued meats are smoked onsite in a hickory wood burning pit. Dickey’s proudly believes there’s no shortcut to true barbecue and it’s why they never say bbq. The Dallas-based, family-run barbecue franchise offers several slow-smoked meats and wholesome sides with ‘No B.S. (Bad Stuff)’ included. The fast-casual concept has expanded worldwide with two international locations in the UAE and operates over 500 locations in 44 states. In 2016, Dickey’s won first place on Fast Casual’s “Top 100 Movers and Shakers” list and was named a Top 500 Franchise by Entrepreneur in 2018. Dickey’s Barbecue Pit has also been recognized by Fox News, Franchise Times, The Wall Street Journal, QSR Magazine, Forbes Magazine and Nation’s Restaurant News. For more information, visit www.dickeys.com.

 

# # #

Attachment



Greer Martin
Dickey's Barbecue Restaurants, Inc.
9729713898
[email protected]

Bipartisan Lawmakers to Appropriators: Follow the House Lead and Protect Wild Horses

Washington D.C., Nov. 25, 2020 (GLOBE NEWSWIRE) — Today, lawmakers in both the U.S. Senate and House of Representatives sent letters to leadership urging them to ensure the final FY21 spending bill contains a key provision to reform the mismanaged and controversial Bureau of Land Management Wild Horse and Burro Program. 

The letters, led by Senator Cory Booker (D-NJ) and Representative Steve Cohen (D-TN), ask Senate and House leadership to ensure that funding for PZP fertility control as an alternative to cruel and costly wild horse roundups is included in any final Fiscal Year 2021 spending deal. 

“As a result of the BLM’s mass roundup strategy and removal mismanagement, there are nearly 48,000 animals in short- and long-term holding, and this number will only increase if the BLM continues to rely primarily on a failed system of mass removals. These holding facilities, like the roundups themselves, are often harmful to the health and well-being of these animals, and efforts to remove horses from the range without supplemental fertility control efforts actually increases population growth rates through compensatory reproduction,” Senator Booker states in the Senate letter.

“The humane treatment of these iconic American horses and burros must remain a priority. I’m proud to lead my colleagues in making that case,” said Representative Steve Cohen (D-TN) of the House letter.

“Congress must not continue to give the BLM carte blanche to mismanage our nation’s iconic wild horse and burro herds,” said Holly Gann, Director of Government Relations for the American Wild Horse Campaign (AWHC). “We commend Senator Booker, Representative Cohen, and their colleagues for standing up for fiscally responsible and humane wild horse management that will benefit both the horses and the American taxpayer.”

This summer, the House passed a bipartisan amendment to its FY21 Interior Appropriations bill to require the BLM to spend $11 million dollars, or just over 10%, of its Wild Horse and Burro Program budget to implement proven and humane PZP fertility control to manage wild horse populations across the West. The Senate version of the bill does not contain the language but Senator Booker, Rep. Cohen and their colleagues are pressing for the final spending bill negotiated between the two chambers to include the provision. 

The agency has accelerated removals of wild horses and burros from public land and is expanding costly corrals to triple the number of animals in holding facilities at taxpayer expense. Currently, 71% of the BLM’s budget is spent on roundup, removal and warehousing wild horses while less than 1% on safe and humane fertility control vaccines to curb population growth on the range. Under the BLM plan, the costs are expected to rise to $1 billion in just the first five years. 

The American Wild Horse Campaign operates the world’s largest wild horse fertility control program in Nevada’s Virginia Range. The program is proving that PZP fertility control is a humane and cost-effective management alternative to roundups. AWHC estimates that the fertility control treatments delivered in the first year of the program will prevent approximately 690 births at a cost of $182,000. In stark contrast, BLM would spend $690,000 to round up those same horses and an astronomical $34.5 million to maintain them in holding facilities for life, resulting in a net cost to taxpayers of $35 million in a single herd area. 

Cosigners of the letters include Sens. Chris Van Hollen (D-MD), Kyrsten Sinema (D-AZ), Dianne Feinstein (D-CA), Catherine Cortez Masto (D-NV), Jacky Rosen (D-NV), and Reps. David Schweikert (R-AZ), Brian Fitzpatrick (R-PA), Joe Neguse (D-CO), Dina Titus (D-NV), Ted Deutch (D-FL), Ted Lieu (D-CA), Peter Defazio (D-OR), Salud Carbajal (D-CA), Deb Haaland (D-NM), Jan Schakowsky (D-IL), Raja Krishnamoorthi (D-IL), Vern Buchanan (R-FL), Gerry Connolly (D-VA), John Katko (R-NY), Raul Grijalva (D-AZ), Barbara Lee (D-CA), Ro Khanna (D-CA), Carolyn Maloney (D-NY), Lucille Roybal-Allard (D-CA), and Alcee Hastings (D-FL).

###

The American Wild Horse Campaign (AWHC) is the nation’s leading wild horse protection organization, with more than 700,000 supporters and followers nationwide. AWHC is dedicated to preserving the American wild horse in viable, free-roaming herds for generations to come, as part of our national heritage.



Grace Kuhn
American Wild Horse Campaign
804-218-4252
[email protected]

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

PR Newswire

SALT LAKE CITY, Nov. 25, 2020 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test as an in vitro diagnostic (“IVD”), intended for the qualitative detection of the SARS-CoV-2 virus.

The Saragene test kit approved by the CDSCO uses the Company’s patented CoPrimer™ technology and is based on a test originally designed by Co-Diagnostics, who also recently announced receipt of a CE marking for its Logix Smart™ SARS-CoV-2 (genes RdRp/E) multiplex test. Both the CoSara and Co-Diagnostics test target two gene markers of the SARS-CoV-2 genome, RdRp and E-gene, to identify the presence of the virus, and were designed to meet the needs of those markets where government or regulatory bodies recommend a multi-target coronavirus diagnostic.

Dwight Egan, CEO of Co-Diagnostics, commented “Tests built on our CoPrimer technology have several advantages over other platforms, including the enhanced multiplex capabilities. We believe that the highly specific nature of the new Saragene test which follows World Health Organization guidance will help CoSara be able to play an even more active role in the battle against this pandemic.”

CoSara Director Mohal Sarabhai remarked “Our honorable Prime Minister Shri Narendra Modi has endorsed the hike in number of available RT-PCR tests to keep the COVID-19 positivity rate under 5%. With this clearance in place, CoSara is geared up for this challenge by providing affordable, high quality, ‘Made in India‘ 2-gene multiplex COVID-19 RT-PCR tests across the country.”

CoSara has previously received CDSCO clearance for RT-PCR tests for Mycobacterium tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (HPV) to be manufactured and sold as IVDs in the Indian market.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Forward-Looking Statements:

This press release contains forward-looking statements. Forward-looking statements can be identified by words such as “believes,” “expects,” “estimates,” “intends,” “may,” “plans,” “will” and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions.  Forward-looking statements in this release include statements regarding the (i) use of funding proceeds, (ii) expansion of product distribution, (iii) acceleration of initiatives in liquid biopsy and SNP detection, (iv) use of the Company’s liquid biopsy tests by laboratories, (v) capital resources and runway needed to advance the Company’s products and markets, (vi) increased sales in the near-term, (vii) flexibility in managing the Company’s balance sheet, (viii) anticipation of business expansion, and (ix) benefits in research and worldwide accessibility of the CoPrimer technology and its cost-saving and scientific advantages. Forward-looking statements are subject to inherent uncertainties, risks and changes in circumstances.  Actual results may differ materially from those contemplated or anticipated by such forward-looking statements. Readers of this press release are cautioned not to rely on any forward-looking statements. Any forward-looking statement made by the Company in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/co-diagnostics-jv-cosara-receives-clearance-from-indian-fda-for-covid-19-2-gene-multiplex-test-301180716.html

SOURCE Co-Diagnostics

Suburban Propane Partners, L.P. Annual Report Available Online

PR Newswire

WHIPPANY, N.J., Nov. 25, 2020 /PRNewswire/ — Suburban Propane Partners, L.P. (NYSE:SPH), a nationwide distributor of propane, fuel oil and related products and services, as well as a marketer of natural gas and electricity, has filed its Annual Report on Form 10-K for its fiscal year ended September 26, 2020 with the Securities and Exchange Commission (“SEC”).

A link to the fiscal 2020 Annual Report on Form 10-K, as filed with the SEC, is available on the Partnership’s website at www.suburbanpropane.com.

Upon written request, the Partnership will provide to any unitholder or noteholder, without charge, a hard copy of its Annual Report on Form 10-K for the year ended September 26, 2020. Requests should be directed to: Suburban Propane Partners, L.P., Investor Relations, P.O. Box 206, Whippany, New Jersey 07981-0206.

Suburban Propane Partners, L.P. is a publicly-traded master limited partnership listed on the New York Stock Exchange. Headquartered in Whippany, New Jersey, Suburban has been in the customer service business since 1928. The Partnership serves the energy needs of approximately 1.0 million residential, commercial, industrial and agricultural customers through approximately 700 locations in 41 states.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/suburban-propane-partners-lp-annual-report-available-online-301180707.html

SOURCE Suburban Propane Partners, L.P.

NextGen Healthcare, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

NextGen Healthcare, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

IRVINE, Calif.–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and Chief Executive Officer, Rusty Frantz, and Chief Financial Officer, Jamie Arnold, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, including a fireside chat presentation and one-on-one meetings with investors, on Tuesday, December 1, 2020. A recording of the fireside chat will be available at investor.nextgen.com.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and oral health providers in their journeys to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Press Contact:

Tami Stegmaier

NextGen Healthcare, Inc.

(949) 237-6083

[email protected]

or

Investor Contacts:

Westwicke

Bob East or Asher Dewhurst

443-213-0500

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Mental Health Health Technology Practice Management Managed Care Software Dental

MEDIA:

Logo
Logo

Citigroup CFO Mark Mason to Present at the Goldman Sachs 2020 U.S. Financial Services Conference

Citigroup CFO Mark Mason to Present at the Goldman Sachs 2020 U.S. Financial Services Conference

NEW YORK–(BUSINESS WIRE)–
Mark Mason, Chief Financial Officer of Citigroup, will present at the Goldman Sachs 2020 U.S. Financial Services Conference held virtually on Wednesday, December 9, 2020. The presentation is expected to begin at approximately 3:20 p.m. (Eastern). A live webcast will be available at www.citigroup.com/citi/investor. A replay and transcript of the webcast will be available shortly after the event.

Citi

Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi

Media: Brendan McManus (212) 793-7064

Investors: Elizabeth Lynn (212) 559-2718

Fixed Income Investors: Thomas Rogers (212) 559-5091

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Banking Other Professional Services Professional Services Finance

MEDIA:

Logo
Logo

Lori A. Johnston Named to Farmers & Merchants Bancorp, Inc. Board of Directors

ARCHBOLD, Ohio, Nov. 25, 2020 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (the “Company”) (NASDAQ: FMAO), the holding company of Farmers & Merchants State Bank (the “Bank”), announced today that the Company’s Board of Directors has increased in size from 12 to 13 members and Lori A. Johnston was appointed to the Board of Directors of both the Company and the Bank.

Ms. Johnston resides in Grand Rapids, Ohio. She is the President of ProMedica Insurance Corporation, an affiliate of ProMedica Health System. She has been employed by ProMedica Health System and affiliates in increasing levels of leadership roles since 1996. Ms. Johnston was employed by Ernst & Young, LLP in Toledo, Ohio from 1983-1996 and is a Certified Public Accountant.

Ms. Johnston is an active member of the Toledo community, serving as a Board Member for various entities including Toledo Mud Hens/Toledo Walleye, Ohio Association of Health Plans, Health Plan Alliance, Compassion Health Toledo and St. Ursula Academy.

“We are extremely pleased to welcome Lori to our Board,” commented Jack Johnson, Board Chairman. “Adding top talent across all areas of the Company, including our Board of Directors, is one of our top strategic initiatives. Lori is a proven leader and will be an asset to our Board and the Company.”

Based on her financial expertise, Ms. Johnston will be serving on the Audit Committee of the Board of Directors.

“Lori will bring great insights across a wide range of experiences to the Board and I look forward to her support as we further the Bank’s growth and financial performance,” said Lars Eller, President and Chief Executive Officer.

About Farmers & Merchants State Bank:

The Farmers & Merchants State Bank is a local independent community bank that has been serving Northwest Ohio and Northeast Indiana since 1897. The Farmers & Merchants State Bank provides commercial banking, retail banking and other financial services through its 30 offices. Our locations are in Fulton, Defiance, Hancock, Henry, Lucas, Williams, and Wood counties in Northwest Ohio. In Northeast Indiana, we have offices located in Adams, Allen, DeKalb, Jay and Steuben counties.

Safe harbor statement

Farmers & Merchants Bancorp, Inc. (“F&M”) wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995. Statements by F&M, including management’s expectations and comments, may not be based on historical facts and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Act of 1934, as amended. Actual results could vary materially depending on risks and uncertainties inherent in general and local banking conditions, competitive factors specific to markets in which F&M and its subsidiaries operate, future interest rate levels, legislative and regulatory decisions or capital market conditions. F&M assumes no responsibility to update this information. For more details, please refer to F&M’s SEC filing, including its most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q. Such filings can be viewed at the SEC’s website, www.sec.gov.

Company Contact: Investor and Media Contact:
Amy Cover
Vice President – Marketing Manager
Farmers & Merchants Bancorp, Inc.
(419) 445-3501 ext. 15436
[email protected] 
Andrew M. Berger
Managing Director
SM Berger & Company, Inc.
(216) 464-6400
[email protected]